NasdaqCM - Nasdaq Real Time Price USD

InMed Pharmaceuticals Inc. (INM)

2.3450
-0.0250
(-1.05%)
At close: May 9 at 4:00:00 PM EDT
2.2900
-0.06
(-2.35%)
After hours: May 9 at 7:46:03 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
4,832.0130
4,597.7300
4,135.5610
1,089.4350
0
Cost of Revenue
3,122.1770
3,496.8170
2,732.5250
545.8890
0
Gross Profit
1,709.8360
1,100.9130
1,403.0360
543.5460
0
Operating Expense
9,475.5410
9,235.3430
9,781.8230
14,335.3020
9,938.2830
Operating Income
-7,765.7050
-8,134.4300
-8,378.7870
-13,791.7560
-9,938.2830
Net Non Operating Interest Income Expense
-38.8210
527.9010
492.4400
96.0900
-344.3330
Other Income Expense
-101.8030
-61.9210
-48.1750
-4,904.4510
79.5270
Pretax Income
-7,906.3290
-7,668.4500
-7,934.5220
-18,600.1170
-10,203.0890
Tax Provision
7.1000
7.1000
13.1000
0
--
Net Income Common Stockholders
-7,913.4290
-7,675.5500
-7,947.6220
-18,600.1170
-10,203.0890
Diluted NI Available to Com Stockholders
-7,913.4290
-7,675.5500
-7,947.6220
-18,600.1170
-10,203.0890
Basic EPS
-12.42
-20.20
-65.00
-663.40
-759.20
Diluted EPS
-12.42
-20.20
-65.00
-663.40
-759.20
Basic Average Shares
570.3080
381.0530
122.4220
28.0410
13.4390
Diluted Average Shares
570.3080
381.0530
122.4220
28.0410
13.4390
Rent Expense Supplemental
77.7200
--
--
--
--
Total Expenses
12,597.7180
12,732.1600
12,514.3480
14,881.1910
9,938.2830
Net Income from Continuing & Discontinued Operation
-7,913.4290
-7,675.5500
-7,947.6220
-18,600.1170
-10,203.0890
Normalized Income
-7,826.8965
-7,622.9172
-7,918.7170
-13,695.6660
-10,282.6160
Interest Income
312.7280
527.9010
492.4400
96.0900
16.0170
Interest Expense
--
--
--
0
360.3500
Net Interest Income
-38.8210
527.9010
492.4400
96.0900
-344.3330
EBIT
-8,020.7600
-8,134.4300
-8,378.7870
-13,791.7560
-9,842.7390
EBITDA
-7,444.1550
-7,529.9120
-7,782.7900
-13,279.9690
-9,614.0450
Reconciled Cost of Revenue
2,762.8870
3,111.8990
2,338.7770
219.7590
0
Reconciled Depreciation
576.6050
604.5180
595.9970
511.7870
228.6940
Net Income from Continuing Operation Net Minority Interest
-7,913.4290
-7,675.5500
-7,947.6220
-18,600.1170
-10,203.0890
Total Unusual Items Excluding Goodwill
-101.8030
-61.9210
-48.1750
-4,904.4510
79.5270
Total Unusual Items
-101.8030
-61.9210
-48.1750
-4,904.4510
79.5270
Normalized EBITDA
-7,342.3520
-7,467.9910
-7,734.6150
-8,375.5180
-9,693.5720
Tax Rate for Calcs
0.0002
0.0002
0.0004
0
0
Tax Effect of Unusual Items
-15.2705
-9.2882
-19.2700
0
0
6/30/2021 - 5/5/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CBWTF Auxly Cannabis Group Inc.
0.0640
+1.59%
 
CWEB.TO Charlotte's Web Holdings, Inc.
0.1150
+4.55%
 
TILT.NE TILT Holdings Inc.
0.0100
0.00%
 
AAWH-U.CN Ascend Wellness Holdings, Inc.
0.3800
-2.56%
 
VEXT.CN Vext Science, Inc.
0.1100
-4.35%
 
AGH.AX Althea Group Holdings Limited
0.0230
0.00%
 
IMCC.CN IM Cannabis Corp.
2.2000
-10.20%
 
PRFX PainReform Ltd.
1.8600
-4.12%
 
BFRI Biofrontera Inc.
0.6949
-4.47%
 
OPTI.CN Optimi Health Corp.
0.2400
0.00%